"L’IRCCS Ospedale San Raffaele è una struttura clinica-scientifica-universitaria di rilievo internazionale e di alta specializzazione per diverse importanti patologie, riconosciuta nel 1972 “Istituto di Ricovero e Cura a Carattere Scientifico” (IRCCS). La tematica della Medicina Molecolare è sempre stata l’elemento caratterizzante di questa Istituzione che ha scelto di focalizzare verso la comprensione dei processi molecolari e le applicazioni mediche delle scoperte della biologia molecolare con lo scopo di sviluppare terapie innovative per le patologie del sistema nervoso centrale e periferico, dell’apparato cardiovascolare e del metabolismo, per le patologie tumorali, le malattie infettive e immunomediate, le malattie genetiche e rare."

During the past decade, Irccs Ospedale San Raffaele;U.O. Oculistica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irccs Ospedale San Raffaele;U.O. Oculistica" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Irccs Ospedale San Raffaele;U.O. Oculistica" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (2 trials), "Central Retinal Vein Occlusion" (1 trials), "Hemiretinal Vein Occlusion" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Irccs Ospedale San Raffaele;U.O. Oculistica" in a lesser frequency.

Most popular intervention types in "Irccs Ospedale San Raffaele;U.O. Oculistica" are "Drug" (7 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "Port Delivery System with Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irccs Ospedale San Raffaele;U.O. Oculistica" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Irccs Ospedale San Raffaele;U.O. Oculistica". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Irccs Ospedale San Raffaele;U.O. Oculistica, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Irccs Ospedale San Raffaele;U.O. Oculistica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".